Andrew Booth - 27 Feb 2026 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Signature
Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
27 Feb 2026
Net transactions value
+$145,692
Form type
4
Filing time
27 Feb 2026, 14:48:34 UTC
Previous filing
05 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Booth Andrew Chief Financial Officer C/O ABCELLERA BIOLOGICS INC, 150 W 4TH AVENUE, VANCOUVER, BRITISH COLUMBIA, CANADA Tryn Stimart, attorney-in-fact 27 Feb 2026 0001834411

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $145,692 +42,600 +28% $3.42 195,600 27 Feb 2026 Direct
holding ABCL Common Shares 130,959 27 Feb 2026 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.